31 employees
Eton Pharmaceuticals develops proprietary formulations of approved molecules in ways that offer improvements for patients and physicians.
2017
$11M
from 2 investors over 2 rounds
Eton Pharmaceuticals, Inc raised $11M on April 1, 2021
Investors: Liquid Venture Partners, LLC
Eton Pharmaceuticals, Inc raised undisclosed on October 16, 2020